Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. OXBR
OXBR logo

OXBR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Oxbridge Re Holdings Ltd (OXBR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.950
1 Day change
-7.28%
52 Week Range
2.860
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Oxbridge Re Holdings Ltd (OXBR) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock lacks significant positive momentum, has no recent news or catalysts, and its technical indicators do not suggest a clear entry point. Additionally, the absence of recent congress trading data, financial performance insights, or strong trading signals makes it prudent to hold off on investing in this stock at this time.

Technical Analysis

The MACD is slightly positive at 0.0042 and expanding, indicating mild bullish momentum. However, the RSI is neutral at 52.28, and moving averages are converging, suggesting no clear trend. Key support is at $0.752, and resistance is at $1.088, but the stock is trading close to its pivot level of $0.92.

Positive Catalysts

  • The company is exploring tokenization technology for insurers' reinsurance and entering the AI data center market, which could be growth drivers in the long term.

Neutral/Negative Catalysts

  • The stock has experienced a regular market drop of -7.30%, and analysts have lowered price targets from $5 to $3 due to reduced internal reinsurance activity. Additionally, there is a lack of significant hedge fund or insider trading activity, and the stock trend analysis predicts further potential declines in the short term.

Financial Performance

No financial performance data available for analysis due to data error.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Maxim maintains a Buy rating but has lowered the price target from $5 to $3, reflecting reduced internal reinsurance activity and a shift toward third-party tokenization sales.

Wall Street analysts forecast OXBR stock price to rise
Analyst Rating
0
Wall Street analysts forecast OXBR stock price to rise
Buy
Hold
Sell
0
Current: 1.030
sliders
Low
0
Averages
0
High
0
0
Current: 1.030
sliders
Low
0
Averages
0
High
0
Maxim
Maxim
Buy
downgrade
$5 -> $3
AI Analysis
2026-06-16
New
Reason
Maxim
Maxim
Price Target
$5 -> $3
AI Analysis
2026-06-16
New
downgrade
Buy
Reason
Maxim lowered the firm's price target on Oxbridge Re Holdings to $3 from $5 and keeps a Buy rating on the shares. The two biggest initiatives for the company are providing tokenization technology for other insurers' reinsurance and entering the AI data center market, though the firm is lowering its 2026 and 2027 estimates to reflect less internal reinsurance activity and more third-party tokenization sales, the analyst tells investors in a research note.

People Also Watch